Sreoshi Chatterjee 452 posts 0 comments

Mylan N.V, which is a global pharmaceutical company asserted receipt of tentative approval from the U.S Food and Drug Administration under the U.S President's Emergency Plan for AIDS…
Read More...

Achieve Life Sciences which is a clinical-stage pharmaceutical company devoted to the global development and commercialization of cytisine ensuring routing smoking or terminating…
Read More...

KAND567 is an orally available small molecule that blocks CX3CR1, the Fractalkine receptor. It is to be noted that Fractalkine receptor is an immunomodulating factor termed as …
Read More...

PTC Therapeutics asserted that the office of New Drugs of the U.S Food and Drug Administration has reaffirmed the FDA's former position quashing PTC's appeal of the Complete Response…
Read More...

Catheter Precision Inc. asserted the launch of a pivotal Clinical Trial to evaluate the safety and accuracy of the VIVO Non-Invasive Mapping system. The VIVO system is designed to…
Read More...

Alcyone Lifesciences, a company focused on transforming disease modifying therapies for central nervous system disorders asserted the demarcation of its Hydrocephalus business.…
Read More...

Micromedic Technologies declared successful results of a Clinical study designed to detect prostate cancer cells in urine specimens using its CellDetect technology. The study…
Read More...

Maker of innovative, needle-free injection technology,  PharmaJet asserted venturing into a global license agreement with  Genexine, for the development and commercialization of DNA…
Read More...

Clinical-stage biopharmaceutical company,Wize Pharma aiming to undertake treatment of opthalmic disorders asserted having received Institutional Review Board approval for the protocol…
Read More...

Axiom Foods has clinched its first application patent for rice protein, US patent no. 9,820,504 for its Oryzatein rice protein. Since November, 2017, Axiom has been granted exclusive…
Read More...